Empowered Patient Podcast

Dr. Este Geraghty, Chief Medical Officer, Esri emphasizes the importance of location in tracking and understanding the spread of COVID-19. Esri is providing geo-spatial visualization tools to world-wide public health organizations, hospitals, and businesses to help them see how the pandemic is impacting them in real time. This GIS data is also enabling some existing predictive models to include a spatial perspective which can reveal new connections and hot-spots needing action.

@Esri_health #Esri #Coronavirus #COVID19 #GIS

Esri.com

coronavirus-resources.esri.com

Seeing what others can't

Listen to the podcast here

Dr. Este Geraghty, Chief Medical Officer, Esri emphasizes the importance of location in tracking and understanding the spread of COVID-19. Esri is providing geo-spatial visualization tools to world-wide public health organizations, hospitals, and businesses to help them see how the pandemic is impacting them in real time. This GIS data is also enabling some existing predictive models to include a spatial perspective which can reveal new connections and hot-spots needing action.

@Esri_health #Esri #Coronavirus #COVID19 #GIS

Esri.com

coronavirus-resources.esri.com

Seeing what others can't

Download the transcript here

Linda Fischer, Vice President of Product Strategy, DrFirst shines the light on the challenges of those who are fighting a relapse of addiction after they have received treatment in a traditional setting for substance abuse. With conditions and restrictions created by the COVID-19 pandemic, the use of telemedicine is becoming even more relevant as a way to connect doctors and patients and continue the support that can be drawn from others fighting these mental health issues.

@DrFirst #Coronavirus #COVID19

DrFirst.com

Listen to the podcast here

Linda Fischer, Vice President of Product Strategy, DrFirst shines the light on the challenges of those who are fighting a relapse of addiction after they have received treatment in a traditional setting for substance abuse. With conditions and restrictions created by the COVID-19 pandemic, the use of telemedicine is becoming even more relevant as a way to connect doctors and patients and continue the support that can be drawn from others fighting these mental health issues.

@DrFirst #Coronavirus. #COVID19

DrFirst.com

Download the transcript here

Maria Picone, Founder, TREND.community and Shelley Bowen, Founder and Director, Barth Syndrome Foundation explain the challenges doctors face in diagnosing a rare disease like Barth Syndrome, the need to educate doctors about symptoms and warning signs of rare diseases, the need for genetic testing to further inform about the possibilities of a rare disease, and the work that is being done to inform patients and their parents about the resources available to support their efforts to find a treatment.

@TRENDcommunity @BarthSyndrome #rarediseases #BarthSyndrome #GeneticDisease

TREND.community

BarthSyndrome.org

Listen to the podcast here

Maria Picone, Founder, TREND.community and Shelley Bowen, Founder and Director, Barth Syndrome Foundation explain the challenges doctors face in diagnosing a rare disease like Barth Syndrome, the need to educate doctors about symptoms and warning signs of rare diseases, the need for genetic testing to further inform about the possibilities of a rare disease, and the work that is being done to inform patients and their parents about the resources available to support their efforts to find a treatment.

@TRENDcommunity @BarthSyndrome #rarediseases #BarthSyndrome #GeneticDisease

TREND.community

BarthSyndrome.org

Download the transcript here

Dr. Gregory Frost, Chairman and CEO, EXUMA Biotech, shares his insights into the tremendous progress made in developing autologous CAR-T therapies, as well as the challenges that remain for cell therapies surrounding safety and accessibility. EXUMA's rapid point of care platform has the potential to dramatically reduce the cost of CAR-T production for both liquid and solid tumors. Greg also describes their logic-gated CAR-T technology which may help avoid potential on-target, off-tumor toxicity in solid tumor malignancies such as gastric, breast and ovarian cancers.

@EXUMABiotech

#EXUMABiotech #CART #CellTherapy #immunotherapy

EXUMABio.com

Listen to the podcast here

Dr. Gregory Frost, Chairman and CEO, EXUMA Biotech, shares his insights into the tremendous progress made in developing autologous CAR-T therapies, as well as the challenges that remain for cell therapies surrounding safety and accessibility. EXUMA's rapid point of care platform has the potential to dramatically reduce the cost of CAR-T production for both liquid and solid tumors. Greg also describes their logic-gated CAR-T technology which may help avoid potential on-target, off-tumor toxicity in solid tumor malignancies such as gastric, breast and ovarian cancers.

@EXUMABiotech

#EXUMABiotech #CART #CellTherapy #immunotherapy

EXUMABio.com

Download the transcript here

Geert Kersten, CEO, Cel-Sci draws on his history working on cancer immunotherapy to talk about the opportunities for treating the COVID-19 virus by generating the right kind of immune response without additional inflammation. Entering into a partnership with the University of Georgia Center for Vaccines and Immunology, Cel-Sci is using their LEAPS technology to apply their knowledge from work done with the US government on H1N1 to see if they can treat patients with coronavirus.

@CelSciCorp

#COVID19 #Coronavirus #Immunotherapy #TCells

Cel-Sci.com

Listen to the podcast here

Geert Kersten, CEO, Cel-Sci draws on his history working on cancer immunotherapy to talk about the opportunities for treating the COVID-19 virus by generating the right kind of immune response without additional inflammation. Entering into a partnership with the University of Georgia Center for Vaccines and Immunology, Cel-Sci is using their LEAPS technology to apply their knowledge from work done with the US government on H1N1 to see if they can treat patients with coronavirus.

@CelSciCorp

#COVID19 #Coronavirus #Immunotherapy #TCells

Cel-Sci.com

Download the transcript here